Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate for painful diabetic neuropathy
2007-002461-12Phase 2Completed
- Sponsor
- BIAL
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of eslicarbazepine acetate in diabetic neuropathy, sponsored by BIAL. Primary endpoint: Change in mean pain intensity from baseline to end of treatment. Started Jul 2007; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on 2007-002461-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002461-12.